Login

KUBOTA PHARMACEUTICAL HOLDINGS CO LTD SEC Filings

Filed On Filing
11 Dec 2017 EFFECT
07 Dec 2017 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
07 Dec 2017 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3
07 Dec 2017 15F-12G/A
06 Dec 2017 15F-12G
09 Nov 2017 6-K
08 Aug 2017 6-K
26 Jul 2017 8-K: Other Events
18 Jul 2017 Form 4: Scheibler Lukas, EVP of Research & Development

Received 2,663 shares by exercise or conversion · Sold 1,250 shares ($8.13K)

05 Jul 2017 Form 4: Gebhart John E, Chief Financial Officer

Received 7,473 shares by exercise or conversion · Sold 3,700 shares ($25K)

05 Jul 2017 Form 4: Danse Edward H, Chief Business Officer

Sold 1,175 shares ($7.93K)

20 Jun 2017 Form 4: Scheibler Lukas, EVP of Research & Development

Received 2,664 shares by exercise or conversion · Sold 1,300 shares ($9.04K)

02 Jun 2017 Form 4: Gebhart John E, Chief Financial Officer

Received 7,473 shares by exercise or conversion · Sold 3,380 shares ($24.9K)

02 Jun 2017 Form 4: Danse Edward H, Chief Business Officer

Sold 1,080 shares ($7.97K)

26 May 2017 8-K: Submission of Matters to a Vote of Security Holders; Other Events
25 May 2017 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
18 May 2017 Form 4: Scheibler Lukas, EVP of Research & Development

Received 2,663 shares by exercise or conversion · Sold 1,275 shares ($7.84K)

10 May 2017 10-Q
10 May 2017 8-K: Results of Operations and Financial Condition
02 May 2017 Form 4: Danse Edward H, Chief Business Officer

Sold 1,100 shares ($6.77K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support